Literature DB >> 16742414

Purine-phosphoribosyltransferase activities in rat and mouse tissues and in Ehrlich ascites-tumour cells.

A W Murray1.   

Abstract

1. The activities of adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase in extracts of rat and mouse liver, brain, spleen, heart and kidney, of rat bone marrow and of Ehrlich ascites-tumour cells have been measured. The specific activity of adenine phosphoribosyltransferase in tumour cells (3mmu-moles of nucleotide formed/min./mg. of protein) was between 15 and 60 times the activity of any mouse tissue examined. Hypoxanthine-phosphoribosyltransferase activity was greater in extracts of tumour cells than in mouse tissues, but the difference was not great. 2. The specific activities of both adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase in ascites-tumour cells decreased respectively by 57% and 36% 2 days after the cells had been inoculated into mice. After 4 days of tumour growth the specific activities of both enzymes increased, reaching a maximum at 10 days. 3. The activity of adenine phosphoribosyltransferase in rat-liver extracts increased steadily up to 4 days after partial hepatectomy, and was still above the control value after 14 days. Hypoxanthine-phosphoribosyltransferase activity in extracts of regenerating rat liver did not increase until the second day after operation and had begun to decrease by the fourth day. 4. From the results it was concluded that adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase may be physiologically important enzymes in rapidly growing tissues, and that inhibitors of the former enzyme have potential value in chemotherapy.

Entities:  

Year:  1966        PMID: 16742414      PMCID: PMC1265199          DOI: 10.1042/bj1000664

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO.

Authors:  A P KIMBALL; G A LEPAGE
Journal:  Cancer Res       Date:  1963-12       Impact factor: 12.701

2.  EARLY CHANGES IN PYRIMIDINE BIOSYNTHESIS AFTER PARTIAL HEPATECTOMY.

Authors:  E BRESNICK
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

3.  SYNTHESIS OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE FROM GLUCOSE IN EHRLICH ASCITES TUMOR CELLS IN VITRO.

Authors:  J F HENDERSON; M K KHOO
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

4.  PURINE NUCLEOTIDE PYROPHOSPHORYLASES IN 6-MERCAPTOPURINE-SENSITIVE AND -RESISTANT HUMAN LEUKEMIAS.

Authors:  J D DAVIDSON; T S WINTER
Journal:  Cancer Res       Date:  1964-02       Impact factor: 12.701

5.  PAPER CHROMATOGRAPHIC SEPARATION OF NUCLEOTIDES, NUCLEOSIDES, PURINES, AND PYRAMIDINES.

Authors:  E GERLACH; R H DREISBACH; B DEUTICKE
Journal:  J Chromatogr       Date:  1965-04

6.  Enzyme studies with mutant mammalian cells.

Authors:  I LIEBERMAN; P OVE
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

7.  Dependence of bone marrow cells on the liver for purine supply.

Authors:  L G LAJTHA; J R VANE
Journal:  Nature       Date:  1958-07-19       Impact factor: 49.962

8.  The incorporation of 14C-formate into nucleic acid bases in vitro and in vivo.

Authors:  J N DAVIDSON; R GOUTIER; R M SMELLIE; R Y THOMSON
Journal:  Biochim Biophys Acta       Date:  1956-12

9.  INHIBITION BY 6-MERCAPTOPURINE OF PURINE PHOSPHORIBOSYLTRANSFERASES FROM EHRLICH ASCITES-TUMOUR CELLS THAT ARE RESISTANT TO THE DRUG.

Authors:  M R ATKINSON; A W MURRAY
Journal:  Biochem J       Date:  1965-01       Impact factor: 3.857

10.  INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.

Authors:  M R ATKINSON; A W MURRAY
Journal:  Biochem J       Date:  1965-01       Impact factor: 3.857

  10 in total
  11 in total

1.  Developmental changes in purine phosphoribosyltransferases in human and rat tissues.

Authors:  A Adams; R A Harkness
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

2.  Analogues of ribose 5-phosphate and 5-phosphoribosyl pyrophosphate. The preparation and properties of ribose 5-phosphorothioate and 5-phosphoribosyl 1-methylenediphosphonate.

Authors:  A W Murray; P C Wong; B Friedrichs
Journal:  Biochem J       Date:  1969-05       Impact factor: 3.857

3.  Regulation of adenylate deaminase from Ehrlich ascites-tumour cells by a phosphonate analogue of adenosine triphosphate.

Authors:  M R Atkinson; A W Murray
Journal:  Biochem J       Date:  1967-07       Impact factor: 3.857

4.  Studies on the nature of the regulation by purine nucleotides of adenine phosphoribosyltransferase and of hypoxanthine phosphoribosyltransferase from Ehrlich ascites-tumour cells.

Authors:  A W Murray
Journal:  Biochem J       Date:  1967-04       Impact factor: 3.857

5.  Inhibition of purine phosphoribosyltransferases from Ehrlich ascites-tumour cells by purine nucleotides.

Authors:  A W Murray
Journal:  Biochem J       Date:  1966-09       Impact factor: 3.857

6.  Stimulation of adenine phosphoribosyltransferase by adenosine triphosphate and other nucleoside triphosphates.

Authors:  A W Murray; P C Wong
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

7.  The activities and kinetic properties of purine phosphoribosyltransferases in developing mouse liver.

Authors:  A W Murray
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

8.  Effect of undernutrition on some enzymes involved in the salvage pathway of purine nucleotides in different regions of developing rat brain.

Authors:  A Vanella; M L Barcellona; I Serra; N Ragusa; R Avola; M Avitabile; A M Giuffrida
Journal:  Neurochem Res       Date:  1983-02       Impact factor: 3.996

9.  Purification of IMP:pyrophosphate phosphoribosyltransferases, catalytically incompetent enzymes in Lesch-Nyhan disease.

Authors:  C S Rubin; J Dancis; L C Yip; R C Nowinski; M E Balis
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Pyrazolopyrimidine metabolism in parasitic protozoa.

Authors:  B Ullman
Journal:  Pharm Res       Date:  1984-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.